Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
4
100Ṁ1052026
38%
chance
1D
1W
1M
ALL
This category of drug is finding more and more uses for a variety of conditions, but the history of drugs, and weight loss drugs in particular, is legally fraught (Phen-Fen, etc.) Are we irrationally exuberant about GLP1 or is it different this time?
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
1,000Sort by:
How long do we think this will take to resolve and will we learn for how much?
Related questions
Related questions
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance
Will Lantern Biotech get sued for over $1M by 2029?
31% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
17% chance
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
42% chance
[M$5k subsidy] Will any FDA-approved GLP-1 agonists be withdrawn from the market for safety reasons by...
Will a large insurance company cover weight loss drugs before 2027?
86% chance
Will an AI-designed drug get FDA approval by the end of 2025?
21% chance